This document discusses dry powder inhalers (DPIs) and their potential uses beyond treating asthma and COPD. Currently, most DPIs are used to treat these conditions. However, DPIs may enable new applications such as delivering vaccines without needles. Key challenges for new uses include ensuring accurate and repeatable dosing. Exciting potential developments include inhaled insulin, migraine treatments, and tuberculosis vaccines delivered via DPIs. The future of DPIs could involve devices that are simple, low-cost, accurate, efficient, and safe while providing desirable and intuitive delivery of high-payload medications.